News

The health system has seen big improvements in how it engages, retains and serves its consumers, including more than 200,000 ...
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...
Contingency management interventions for stimulant and opioid use disorders should offer $128 per week for vouchers or $55 ...
Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry ...
Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...
CRISPR Therapeutics could stage a comeback thanks to clinical and commercial progress. There are many promising corporations ...
As the pioneer of the industry's first Enterprise Clinical Data Management (eCDM™) platform, Q-Centrix integrates proprietary technology, the largest and most diverse team of clinical data ...
MRO Corp, which is backed by Parthenon, has acquired Q-Centrix Corp, a Chicago-based enterprise clinical data management platform. The seller was TPG Growth. No financial terms were disclosed.
Lakshmi Priya Darshini Pulavarthi blends scientific expertise with data management to drive clinical trial success across oncology, hematology, and cardiovascular therapeutic areas.
With 80% of clinical trial data coming from unstructured sources, LUCCID solves the critical bottleneck tied to the manual extraction and transformation of unstructured data for trials.
These data reinforce the clinical potential of zoldonrasib following the initial tolerability and antitumor activity reported late last year in patients with pancreatic ductal adenocarcinoma,” said ...